Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ahmed Abdulla Deemas Alsuwaidi currently holds 33,920,000 shares of CALYPTE BIOMEDICAL CORP (CBMC.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ahmed Abdulla Deemas Alsuwaidi has been a net neutral trader of CBMC.OB stock. They have purchased $0 and sold $0 worth of shares.
Ahmed Abdulla Deemas Alsuwaidi's most recent insider trade was on Jul 21, 2008, when they sold 9,920,000 shares at $0.05 per share.
Ahmed Abdulla Deemas Alsuwaidi serves as Executive at CALYPTE BIOMEDICAL CORP (CBMC.OB). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Ahmed Abdulla Deemas Alsuwaidi holds the position of Executive at CALYPTE BIOMEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Ahmed Abdulla Deemas Alsuwaidi has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Ahmed Abdulla Deemas Alsuwaidi was on Jul 21, 2008, when they sold $496.0K worth of CBMC.OB shares. This transaction involved 9,920,000 shares at $0.05 per share.
Ahmed Abdulla Deemas Alsuwaidi currently owns 33,920,000 shares of CALYPTE BIOMEDICAL CORP (CBMC.OB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ahmed Abdulla Deemas Alsuwaidi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ahmed Abdulla Deemas Alsuwaidi has 2 Form 4 filings on record as an insider at CALYPTE BIOMEDICAL CORP.
Set alerts for Ahmed Abdulla Deemas Alsuwaidi and 40,000+ other insiders.